Biotest Pharmaceuticals Corporation (BPC), a leading developer of immunology biotherapeutic products, is pleased to announce that it has opened a new plasma collection center. The state-of-the-art, 15,000 square foot facility located at 113 Yopp Road, Jacksonville, North Carolina, is BPC's second plasma center in Jacksonville, and officially opened its doors for business on February 3, 2015.
"We continue to expand our U.S. plasma collection operations to better serve the thousands of patients world-wide who rely on plasma based therapies," said Jordan Siegel, BPC's Chief Executive Officer.
The plasma donated at Biotest Plasma Centers is used to manufacture critical care therapies that treat life-threatening disorders in a variety of therapeutic areas, such as BPC's BIVIGAM® [Immune Globulin Intravenous (Human), 10% Liquid] and Nabi-HB® [Hepatitis B Immune Globulin (Human)].
BPC expects to add more than 50 jobs to Jacksonville's local economy and currently has career opportunities available for Licensed Practical Nurses/Registered Nurses, phlebotomists and various other positions. In addition to supporting the local economy through employment opportunities, the center is actively recruiting plasma donors.
Mount Sinai researchers develop MARQO to revolutionize cancer tissue analysis